Dr Reddy's inks pact with Gilead to manufacture COVID-19 drug
Posted by
www.biotecnika.org
As per the non-exclusive licensing agreement, Gilead will grant the
Hyderabad-based drug maker the right to register and manufacture its
investigational drug Remdesivir in 127 countries, Dr Reddy's
Laboratories said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-inks-pact-with-gilead-to-manufacture-covid-19-drug/articleshow/76356477.cms
Subscribe to:
Post Comments (Atom)
Post a Comment